Skip to main content
Erschienen in: Surgical Endoscopy 10/2020

28.10.2019

Effects of laparoscopic vs open abdominal surgery on costs and hospital readmission rate and its effect modification by surgeons’ case volume

verfasst von: Thomas H. Shin, Sabine Friedrich, Gabriel A. Brat, Maira I. Rudolph, Vicki Sein, Ronny Munoz-Acuna, Timothy T. Houle, Cristina R. Ferrone, Matthias Eikermann

Erschienen in: Surgical Endoscopy | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Laparoscopy provides a minimally invasive alternative to open abdominal surgery. Current data describing its association with hospital readmission and costs in relation to surgeon laparoscopic case volume is limited to smaller databases and subsets of operations.

Methods

This retrospective cohort study of 23,285 adult abdominal operations from 2007 to 2015 compares 30-day readmission rate and costs between laparoscopic and open abdominal operations and examines effect modification by surgeon laparoscopic case volume. Outcomes were all-cause hospital readmission within 30 days after discharge and index hospital admission cost.

Results

All-cause hospital readmission rates were significantly lower after laparoscopic abdominal operations compared with open operations (adjusted odds ratio [aOR] 0.56, 95% CI 0.46–0.69, p < 0.001) with a difference in readmission risk attributable to laparoscopic approach of − 4.0% (95% CI − 5.4 to − 2.6%) in complete-case analysis. Among surgeons with a high laparoscopic case volume, the estimated difference in readmission risk through laparoscopy was magnified (− 5.8%, 95% CI − 7.5 to − 4.1%) compared to low surgeon laparoscopic case volume (− 2.9%, 95% CI − 4.8 to −1.1%, p for interaction = 0.005). The estimated difference in costs of the index hospital admission attributable to laparoscopic approach was − $3869 (95% CI − $4200 to − $3538; adjusted incidence rate ratio 0.77, 95% CI 0.75–0.79, p < 0.001). Laparoscopy was followed by significantly lower rates of readmissions related to gastrointestinal (aOR 0.68, 95% CI 0.55–0.85, p = 0.001), wound complications (infection: aOR 0.33, 95% CI 0.23–0.47, p < 0.001; non-infectious: aOR 0.47, 95% CI 0.30–0.74, p = 0.001), and malignancy (aOR 0.68, 95% CI 0.55–0.85, p < 0.001). The findings remain robust after multiple imputation and sensitivity analyses.

Conclusions

Laparoscopy versus open abdominal surgery is associated with reduced hospital readmissions related to malignancy, gastrointestinal, and wound complications. Effect modification by higher laparoscopy case volume argues for continued proliferation of laparoscopy in abdominal surgeries.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Karayiannakis AJ, Makri GG, Mantzioka A, Karousos D, Karatzas G (1996) Postoperative pulmonary function after laparoscopic and open cholecystectomy. Br J Anaesth 77:448–452CrossRef Karayiannakis AJ, Makri GG, Mantzioka A, Karousos D, Karatzas G (1996) Postoperative pulmonary function after laparoscopic and open cholecystectomy. Br J Anaesth 77:448–452CrossRef
6.
Zurück zum Zitat Brenkman HJF, Gisbertz SS, Slaman AE, Goense L, Ruurda JP, van Berge Henegouwen MI, van Hillegersberg R, Dutch Upper Gastrointestinal Cancer Audit (DUCA) group (2017) Postoperative outcomes of minimally invasive gastrectomy versus open gastrectomy during the early introduction of minimally invasive gastrectomy in the Netherlands: a population-based cohort study. Ann Surg 266:831–838. https://doi.org/10.1097/SLA.0000000000002391CrossRefPubMed Brenkman HJF, Gisbertz SS, Slaman AE, Goense L, Ruurda JP, van Berge Henegouwen MI, van Hillegersberg R, Dutch Upper Gastrointestinal Cancer Audit (DUCA) group (2017) Postoperative outcomes of minimally invasive gastrectomy versus open gastrectomy during the early introduction of minimally invasive gastrectomy in the Netherlands: a population-based cohort study. Ann Surg 266:831–838. https://​doi.​org/​10.​1097/​SLA.​0000000000002391​CrossRefPubMed
9.
Zurück zum Zitat Sharma KC, Brandstetter RD, Brensilver JM, Jung LD (1996) Cardiopulmonary physiology and pathophysiology as a consequence of laparoscopic surgery. Chest 110:810–815CrossRef Sharma KC, Brandstetter RD, Brensilver JM, Jung LD (1996) Cardiopulmonary physiology and pathophysiology as a consequence of laparoscopic surgery. Chest 110:810–815CrossRef
12.
28.
Zurück zum Zitat Long DR, Lihn AL, Friedrich S, Scheffenbichler FT, Safavi KC, Burns SM, Schneider JC, Grabitz SD, Houle TT, Eikermann M (2018) Association between intraoperative opioid administration and 30-day readmission: a pre-specified analysis of registry data from a healthcare network in New England. Br J Anaesth 120:1090–1102. https://doi.org/10.1016/j.bja.2017.12.044CrossRefPubMed Long DR, Lihn AL, Friedrich S, Scheffenbichler FT, Safavi KC, Burns SM, Schneider JC, Grabitz SD, Houle TT, Eikermann M (2018) Association between intraoperative opioid administration and 30-day readmission: a pre-specified analysis of registry data from a healthcare network in New England. Br J Anaesth 120:1090–1102. https://​doi.​org/​10.​1016/​j.​bja.​2017.​12.​044CrossRefPubMed
30.
Zurück zum Zitat Thevathasan T, Shih SL, Safavi KC, Berger DL, Burns SM, Grabitz SD, Glidden RS, Zafonte RD, Eikermann M, Schneider JC (2017) Association between intraoperative non-depolarising neuromuscular blocking agent dose and 30-day readmission after abdominal surgery. Br J Anaesth 119:595–605. https://doi.org/10.1093/bja/aex240CrossRefPubMed Thevathasan T, Shih SL, Safavi KC, Berger DL, Burns SM, Grabitz SD, Glidden RS, Zafonte RD, Eikermann M, Schneider JC (2017) Association between intraoperative non-depolarising neuromuscular blocking agent dose and 30-day readmission after abdominal surgery. Br J Anaesth 119:595–605. https://​doi.​org/​10.​1093/​bja/​aex240CrossRefPubMed
34.
35.
Zurück zum Zitat POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet Lond Engl 371:1839–1847. https://doi.org/10.1016/s0140-6736(08)60601-7CrossRef POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Málaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P (2008) Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet Lond Engl 371:1839–1847. https://​doi.​org/​10.​1016/​s0140-6736(08)60601-7CrossRef
38.
Zurück zum Zitat Lukannek C, Shaefi S, Platzbecker K, Raub D, Santer P, Nabel S, Lecamwasam HS, Houle TT, Eikermann M (2019) The development and validation of the Score for the Prediction of Postoperative Respiratory Complications (SPORC-2) to predict the requirement for early postoperative tracheal re-intubation: a hospital registry study. Anaesthesia 74:1165–1174. https://doi.org/10.1111/anae.14742CrossRefPubMedPubMedCentral Lukannek C, Shaefi S, Platzbecker K, Raub D, Santer P, Nabel S, Lecamwasam HS, Houle TT, Eikermann M (2019) The development and validation of the Score for the Prediction of Postoperative Respiratory Complications (SPORC-2) to predict the requirement for early postoperative tracheal re-intubation: a hospital registry study. Anaesthesia 74:1165–1174. https://​doi.​org/​10.​1111/​anae.​14742CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef
40.
Zurück zum Zitat Grabitz SD, Farhan HN, Ruscic KJ, Timm FP, Shin CH, Thevathasan T, Staehr-Rye AK, Kurth T, Eikermann M (2017) Dose-dependent protective effect of inhalational anesthetics against postoperative respiratory complications: a prospective analysis of data on file from three hospitals in New England. Crit Care Med 45:e30–e39. https://doi.org/10.1097/CCM.0000000000002015CrossRefPubMed Grabitz SD, Farhan HN, Ruscic KJ, Timm FP, Shin CH, Thevathasan T, Staehr-Rye AK, Kurth T, Eikermann M (2017) Dose-dependent protective effect of inhalational anesthetics against postoperative respiratory complications: a prospective analysis of data on file from three hospitals in New England. Crit Care Med 45:e30–e39. https://​doi.​org/​10.​1097/​CCM.​0000000000002015​CrossRefPubMed
48.
Zurück zum Zitat Nguyen NT, Goldman C, Rosenquist CJ, Arango A, Cole CJ, Lee SJ, Wolfe BM (2001) Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 234:279–289; discussion 289–291 Nguyen NT, Goldman C, Rosenquist CJ, Arango A, Cole CJ, Lee SJ, Wolfe BM (2001) Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 234:279–289; discussion 289–291
57.
Zurück zum Zitat Hara T, Fujiwara Y, Sugimura K, Kishi K, Motoori M, Miyoshi N, Akita H, Gotoh K, Takahashi H, Marubashi S, Noura S, Ohue M, Sakon M, Yano M (2014) Comparison of early clinical outcomes between laparoscopic total gastrectomy and open total gastrectomy for early-stage gastric cancer. Gan Kagaku Ryoho 41:1476–1478 Hara T, Fujiwara Y, Sugimura K, Kishi K, Motoori M, Miyoshi N, Akita H, Gotoh K, Takahashi H, Marubashi S, Noura S, Ohue M, Sakon M, Yano M (2014) Comparison of early clinical outcomes between laparoscopic total gastrectomy and open total gastrectomy for early-stage gastric cancer. Gan Kagaku Ryoho 41:1476–1478
59.
Metadaten
Titel
Effects of laparoscopic vs open abdominal surgery on costs and hospital readmission rate and its effect modification by surgeons’ case volume
verfasst von
Thomas H. Shin
Sabine Friedrich
Gabriel A. Brat
Maira I. Rudolph
Vicki Sein
Ronny Munoz-Acuna
Timothy T. Houle
Cristina R. Ferrone
Matthias Eikermann
Publikationsdatum
28.10.2019
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 10/2020
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-07222-x

Weitere Artikel der Ausgabe 10/2020

Surgical Endoscopy 10/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.